The Optimization of Medications in Chronic Heart Failure Using a Website

University of Michigan

Status: Terminated

Conditions: Heart Failure

Treatments: Other: Med Optimization Arm

Study type: Interventional

Funder types: Other

Identifiers

NCT04580004

HUM00158766

Details and patient eligibility

About

Heart failure (HF) is the most common hospital discharge diagnosis among older adults in the United States. Strikingly, 2 in 5 patients are readmitted within 1-year following their first HF admission. This results in significant potentially avoidable costs to our already strained healthcare system since hospitalizations result in 70% of yearly HF management costs. One of the most common causes of readmission is lack of medication optimization. This study will determine the effectiveness of a medication optimization website.

Full description

In a prospective design, 100 patients will be randomized to the intervention or usual care in a 1:1 fashion. Patients randomized to the intervention will receive an evidence-based medication recommendation intervention. Outcome measures will be collected at baseline and at 2 weeks post-intervention.

Enrollment: 3 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• left ventricular ejection fraction (LVEF) </= 40%

Exclusion criteria

• pregnancy
• active cancer with a life expectancy less than 12 months
• hospice
• chronic inotropic therapy

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

3 participants in 2 patient groups

Medication Optimization Group

Experimental group

Description:

Patients randomized to the medication optimization group will receive an evidence-based medication recommendation intervention.

Treatment:

Other: Med Optimization Arm

Control Group

No Intervention group

Description:

Patients in the control group will receive the same intervention, delayed 2 weeks after the intervention group. During those initial 2 weeks they will act as a control.